Macleans.caShh . . . the plants are thinkingMacleans.caThose who accept it frequently invoke the names of the giants of science who travelled this path before: Jagadish Chandra Bose, the Indian polymath physicist and biologist, measured electrical sign…
Research and Markets: Iressa (Non-Small Cell Lung Cancer) – Forecast and … – Fort Mills Times
Research and Markets: Iressa (Non-Small Cell Lung Cancer) – Forecast and …Fort Mills TimesNon-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically … Sales information covere…
Artificial hearts help thousands of patients – Pacific Daily News
Artificial hearts help thousands of patientsPacific Daily NewsWith heart failure affecting 5.7 million people in the United States and 400,000 to 700,000 new cases being diagnosed each year, the supply of viable donor organs cannot possibly meet the ne…
Management of Marginal Zone Lymphoma – Cancer Network
Management of Marginal Zone LymphomaCancer NetworkThere are several different treatment approaches for SMZL, including single-agent rituximab, splenectomy, and traditional chemotherapy. Tsimberidou et al evaluated rituximab with or without chemotherapy…
Rolls-Royce grows an Indian heart – Business Standard
Business Standard |
Rolls-Royce grows an Indian heart
Business Standard One of the world’s first ultra-luxury brands is going strong for over 100 years and is even considering an India edition of its product. Rolls-Royce Motors, the automobile arm of Rolls-Royce, and now owned by BMW, announced its designs on India on the … |
Adult Stem Cells, The Future of Medicine: One Patient's Story – LifeNews.com
|
Adult Stem Cells, The Future of Medicine: One Patient’s Story
LifeNews.com Tony applied and was accepted into a similar clinical trial underway with Dr. Richard Burt at Northwestern University in Chicago. Missy says it was miraculous to see the adult stem cells go to work: “When he received the adult stem cell transplant, the … |
Patients with recurrent HCV benefit from triple therapy after liver transplant – Healio
Patients with recurrent HCV benefit from triple therapy after liver transplantHealioIn a multicenter cohort study in France, researchers evaluated 37 patients with recurrent hepatitis C genotype 1 who underwent liver transplantation (LT) and received t…
Max Super Speciality Hospital saves elderly's lif – Times of India
|
Max Super Speciality Hospital saves elderly’s lif
Times of India In conventional practice where a heart-lung machine took over the function of patient’s heart and lungs during the surgery, an Octopus Tissue Stabilizer (OTS), which was designed to position and to hold the heart, gave the surgeon easy access to the … |
Biosimilar Opportunities in an Evolving Market – New Report Available – SBWire (press release)
|
Biosimilar Opportunities in an Evolving Market – New Report Available
SBWire (press release) In terms of revenue, six of the top ten pharmaceutical therapies are biological products, which have been targeted by biosimilar developers: Abbvie’s Humira (adalimumab), Roche’s MabThera (rituximab), Herceptin (trastuzumab) and Avastin (bevacizumab), … |
Children's Hospital of Philadelphia Becomes First Accredited Pediatric Heart … – eReleases (press release)
|
Children’s Hospital of Philadelphia Becomes First Accredited Pediatric Heart …
eReleases (press release) “The heart failure program at The Children’s Hospital of Philadelphia is enthusiastic about working with the Colloquium,” said Dr. Joseph Rossano, Medical Director of Heart Transplantation. “Working together with other Children’s Hospitals throughout … |